{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:28:44Z","timestamp":1786588124137,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-026-02868-z","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T09:55:13Z","timestamp":1780739713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Personalizing adjuvant radiotherapy decisions in breast cancer: an externally test MRI radiomics approach for recurrence risk stratification"],"prefix":"10.1186","volume":"21","author":[{"given":"Man","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiu","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songliang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guili","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuolin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"3","key":"2868_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clinicians. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clinicians"},{"issue":"22","key":"2868_CR2","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1093\/jnci\/88.22.1659","volume":"88","author":"RM Clark","year":"1996","unstructured":"Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. JNCI J Natl Cancer Inst. 1996;88(22):1659\u201364. https:\/\/doi.org\/10.1093\/jnci\/88.22.1659.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"9029","key":"2868_CR3","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/s0140-6736(96)02133-2","volume":"348","author":"AP Forrest","year":"1996","unstructured":"Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet. 1996;348(9029):708\u201313. https:\/\/doi.org\/10.1016\/s0140-6736(96)02133-2.","journal-title":"Lancet"},{"issue":"8","key":"2868_CR4","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1200\/jco.1999.17.8.2326","volume":"17","author":"G Liljegren","year":"1999","unstructured":"Liljegren G, Holmberg L, Bergh J, Lindgren A, Tab\u00e1r L, Nordgren H, et al. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. JCO. 1999;17(8):2326\u20132326. https:\/\/doi.org\/10.1200\/jco.1999.17.8.2326.","journal-title":"JCO"},{"issue":"11","key":"2868_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Br\u00f8nnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1209825.","journal-title":"N Engl J Med"},{"issue":"1","key":"2868_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00066-013-0465-4","volume":"190","author":"MN Duma","year":"2014","unstructured":"Duma MN, Molls M, Trott KR. Eine Herzensangelegenheit f\u00fcr Brustkrebspatientinnen \u2013 kardiovaskul\u00e4re Toxizit\u00e4t der Strahlentherapie beim Mammakarzinom. Strahlenther Onkol. 2014;190(1):5\u20137. https:\/\/doi.org\/10.1007\/s00066-013-0465-4.","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"2868_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.radonc.2014.10.004","volume":"114","author":"T Grantzau","year":"2015","unstructured":"Grantzau T, Overgaard J. Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762, 468 patients. Radiother Oncol. 2015;114(1):56\u201365. https:\/\/doi.org\/10.1016\/j.radonc.2014.10.004.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2868_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijrobp.2014.09.022","volume":"91","author":"JP Pignol","year":"2015","unstructured":"Pignol JP, Vu TTT, Mitera G, Bosnic S, Verkooijen HM, Truong P. Prospective evaluation of severe skin toxicity and pain during postmastectomy radiation therapy. Int J Multiling Radiat Oncol*Biol*Phys. 2015;91(1):157\u201364. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.09.022.","journal-title":"Int J Multiling Radiat Oncol*Biol*Phys"},{"key":"2868_CR9","doi-asserted-by":"publisher","unstructured":"Wishart GC, Azzato EM, Greenberg DC, Rashbass J, Kearins O, Lawrence G, et al. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res. 2010;12(1):R1. https:\/\/doi.org\/10.1186\/bcr2464.","DOI":"10.1186\/bcr2464"},{"issue":"6","key":"2868_CR10","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s12282-015-0649-0","volume":"23","author":"H Yamashita","year":"2016","unstructured":"Yamashita H, Ogiya A, Shien T, Horimoto Y, Masuda N, Inao T, et al. Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer. Breast Cancer. 2016;23(6):830\u201343. https:\/\/doi.org\/10.1007\/s12282-015-0649-0.","journal-title":"Breast Cancer"},{"key":"2868_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2019.12.007","volume":"471","author":"S Huang","year":"2020","unstructured":"Huang S, Yang J, Fong S, Zhao Q. Artificial intelligence in cancer diagnosis and prognosis: opportunities and challenges. Cancer Lett. 2020;471:61\u201371. https:\/\/doi.org\/10.1016\/j.canlet.2019.12.007.","journal-title":"Cancer Lett"},{"issue":"12","key":"2868_CR12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749\u201362. https:\/\/doi.org\/10.1038\/nrclinonc.2017.141.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10423","key":"2868_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/s0140-6736(23)02476-5","volume":"403","author":"GB Mann","year":"2024","unstructured":"Mann GB, Skandarajah AR, Zdenkowski N, Hughes J, Park A, Petrie D, et al. Postoperative radiotherapy omission in selected patients with early breast cancer following preoperative breast MRI (PROSPECT): primary results of a prospective two-arm study. Lancet. 2024;403(10423):261\u201370. https:\/\/doi.org\/10.1016\/s0140-6736(23)02476-5.","journal-title":"Lancet"},{"issue":"3","key":"2868_CR14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10278-023-00781-5","volume":"36","author":"P Chiacchiaretta","year":"2023","unstructured":"Chiacchiaretta P, Mastrodicasa D, Chiarelli AM, Luberti R, Croce P, Sguera M, et al. MRI-Based radiomics approach predicts tumor recurrence in ER + \/HER2 \u2212 early breast cancer patients. J Digit Imag. 2023;36(3):1071\u201380. https:\/\/doi.org\/10.1007\/s10278-023-00781-5.","journal-title":"J Digit Imag"},{"key":"2868_CR15","doi-asserted-by":"publisher","unstructured":"Song Y, Zhang J, Zhang YD, Hou Y, Yan X, Wang Y, et al. FeAture Explorer (FAE): a tool for developing and comparing radiomics models. PLoS One. 2020;15(8):e0237587. https:\/\/doi.org\/10.1371\/journal.pone.0237587.","DOI":"10.1371\/journal.pone.0237587"},{"issue":"21","key":"2868_CR16","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.Ccr-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252\u201359. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-04-0713.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2868_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41571-021-00560-7","volume":"19","author":"K Bera","year":"2022","unstructured":"Bera K, Braman N, Gupta A, Velcheti V, Madabhushi A. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Rev Clin Oncol. 2022;19(2):132\u201346. https:\/\/doi.org\/10.1038\/s41571-021-00560-7.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"2868_CR18","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1158\/1078-0432.Ccr-18-4067","volume":"26","author":"RD Chitalia","year":"2020","unstructured":"Chitalia RD, Rowland J, McDonald ES, Pantalone L, Cohen EA, Gastounioti A, et al. Imaging phenotypes of breast cancer heterogeneity in preoperative breast dynamic contrast enhanced Magnetic resonance imaging (DCE-MRI) scans predict 10-year recurrence. Clin Cancer Res. 2020;26(4):862\u201369. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-4067.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2868_CR19","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/jmri.1125","volume":"13","author":"D James","year":"2001","unstructured":"James D, Clymer BD, Schmalbrock P. Texture detection of simulated microcalcification susceptibility effects in magnetic resonance imaging of breasts. Magn Reson Imag. 2001;13(6):876\u201381. https:\/\/doi.org\/10.1002\/jmri.1125.","journal-title":"Magn Reson Imag"},{"issue":"3","key":"2868_CR20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/mrm.21347","volume":"58","author":"W Chen","year":"2007","unstructured":"Chen W, Giger ML, Li H, Bick U, Newstead GM. Volumetric texture analysis of breast lesions on contrast-enhanced magnetic resonance images. Magnetic Reson Med. 2007;58(3):562\u201371. https:\/\/doi.org\/10.1002\/mrm.21347.","journal-title":"Magnetic Reson Med"},{"issue":"1","key":"2868_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/mrm.10496","volume":"50","author":"P Gibbs","year":"2003","unstructured":"Gibbs P, Turnbull LW. Textural analysis of contrast-enhanced MR images of the breast. Magnetic Reson Med. 2003;50(1):92\u201398. https:\/\/doi.org\/10.1002\/mrm.10496.","journal-title":"Magnetic Reson Med"},{"issue":"2","key":"2868_CR22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00330-015-3845-6","volume":"26","author":"SA Waugh","year":"2016","unstructured":"Waugh SA, Purdie CA, Jordan LB, Vinnicombe S, Lerski RA, Martin P, et al. Magnetic resonance imaging texture analysis classification of primary breast cancer. Eur Radiol. 2016;26(2):322\u201330. https:\/\/doi.org\/10.1007\/s00330-015-3845-6.","journal-title":"Eur Radiol"},{"issue":"1","key":"2868_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13058-017-0846-1","volume":"19","author":"NM Braman","year":"2017","unstructured":"Braman NM, Etesami M, Prasanna P, Dubchuk C, Gilmore H, Tiwari P, et al. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res. 2017;19(1):57. https:\/\/doi.org\/10.1186\/s13058-017-0846-1.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"2868_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10549-018-4990-9","volume":"173","author":"EH Cain","year":"2019","unstructured":"Cain EH, Saha A, Harowicz MR, Marks JR, Marcom PK, Mazurowski MA. Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set. Breast Cancer Res Treat. 2019;173(2):455\u201363. https:\/\/doi.org\/10.1007\/s10549-018-4990-9.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2868_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1148\/radiol.2016160261","volume":"282","author":"JH Kim","year":"2017","unstructured":"Kim JH, Ko ES, Lim Y, Lee KS, Han BK, Ko EY, et al. Breast cancer heterogeneity: MR imaging texture analysis and survival outcomes. Radiology. 2017;282(3):665\u201375. https:\/\/doi.org\/10.1148\/radiol.2016160261.","journal-title":"Radiology"},{"issue":"19","key":"2868_CR26","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1158\/1078-0432.Ccr-17-3783","volume":"24","author":"H Park","year":"2018","unstructured":"Park H, Lim Y, Ko ES, Cho HH, Lee JE, Han BK, et al. Radiomics signature on Magnetic resonance imaging: association with disease-free survival in patients with invasive breast cancer. Clin Cancer Res. 2018;24(19):4705\u201314. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-3783.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2868_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1148\/radiol.14130569","volume":"272","author":"J Parikh","year":"2014","unstructured":"Parikh J, Selmi M, Charles-Edwards G, Glendenning J, Ganeshan B, Verma H, et al. Changes in primary breast cancer heterogeneity may augment midtreatment MR imaging assessment of response to neoadjuvant chemotherapy. Radiology. 2014;272(1):100\u201312. https:\/\/doi.org\/10.1148\/radiol.14130569.","journal-title":"Radiology"},{"issue":"3","key":"2868_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/rli.0000000000000222","volume":"51","author":"MD Pickles","year":"2016","unstructured":"Pickles MD, Lowry M, Gibbs P. Pretreatment prognostic value of Dynamic contrast-enhanced Magnetic resonance imaging vascular, texture, shape, and size parameters compared with traditional survival indicators obtained from locally advanced breast cancer patients. Invest Radiol. 2016;51(3):177\u201385. https:\/\/doi.org\/10.1097\/rli.0000000000000222.","journal-title":"Invest Radiol"},{"issue":"2","key":"2868_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1148\/radiol.2017170143","volume":"286","author":"F Chamming\u2019s","year":"2018","unstructured":"Chamming\u2019s F, Ueno Y, Ferr\u00e9 R, Kao E, Jannot AS, Chong J, et al. Features from computerized texture analysis of breast cancers at pretreatment MR imaging are associated with response to neoadjuvant chemotherapy. Radiology. 2018;286(2):412\u201320. https:\/\/doi.org\/10.1148\/radiol.2017170143.","journal-title":"Radiology"},{"issue":"12","key":"2868_CR30","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/s1470-2045(20)30472-1","volume":"21","author":"PM Poortmans","year":"2020","unstructured":"Poortmans PM, Weltens C, Fortpied C, Kirkove C, Peignaux-Casasnovas K, Budach V, et al. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I\u2013III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial. The Lancet Oncol. 2020;21(12):1602\u201310. https:\/\/doi.org\/10.1016\/s1470-2045(20)30472-1.","journal-title":"The Lancet Oncol"},{"issue":"19","key":"2868_CR31","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1200\/jco.2012.45.2615","volume":"31","author":"KS Hughes","year":"2013","unstructured":"Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. JCO. 2013;31(19):2382\u201387. https:\/\/doi.org\/10.1200\/jco.2012.45.2615.","journal-title":"JCO"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-026-02868-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02868-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02868-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:15:22Z","timestamp":1786587322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-026-02868-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2868"],"URL":"https:\/\/doi.org\/10.1186\/s13014-026-02868-z","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki (2013 revision). This retrospective multicenter study was approved by the local ethics committee (Project Ethics number, KYLX2023-163), and written informed consent was waived for patients.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"106"}}